Normal linear growth in hypophosphataemic bone disease.
A case of hypophosphataemic bone diseases is described. Despite prescribed phosphate (PO4) supplement and 1.25 dihydroxycholecalciferol therapy, serum PO4 levels have remained low with associated diminished theoretical renal threshold for phosphate (TmPO/GFR) over a seven and a half year follow up period. Linear growth, however, has been normal.
Mactier
H
H
Royal Hospital for Sick Children, Yorkhill NHS Trust, Glasgow.
Goel
K M
KM
D001851:Bone Diseases, Metabolic / Q000503:physiopathology / Q000628:therapy; D002675:Child, Preschool; D005260:Female; D006128:Growth; D006801:Humans; D017674:Hypophosphatemia / Q000503:physiopathology / Q000628:therapy